Armenian banking system liabilities grew by 7.17% to 2,145.1 bln drams in Q1

YEREVAN, April 18. /ARKA/. Aggregate liabilities of Armenia’s banking system rose by 7.17% to 2,145.1 billion drams as of the end of March, compared to the beginning of the year.

An analysis made by Arka News Agency showed that Ameriabank had the highest total liabilities among Armenia’s banks – 270.8 billion drams, an increase of 29.96% against the beginning of the year. Ameriabank’s share in the overall aggregate liabilities of the banking system is 12.6%.

Bank VTB (Armenia) recorded the second highest volume of total liabilities, 206.9bln drams (14.01% increase), followed by ACBA_CREDIT AGRICOLE BANK with 202.3bln drams (1.56% increase), Ardshininvestbank with over 185.2bln drams (10.17% increase) and HSBC Bank Armenia, about 184.4bln drams (an increase of 4.81%).

There were 21 commercial banks operating in Armenia as of the end of March 2012. ($1=416.65drams).  –0—

spot_img

POPULAR

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

Acba Bank has issued over 1 million cards, solidifying its leadership in Armenia

YEREVAN, August 17. /ARKA/. For more than five years, Acba Bank has held the top spot in the Armenian card market. As of May 2026, the total number of cards issued by the bank surpassed 1 million, as reported by the bank's press service.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img